New Clinical Trial for Lymphoma Patients

Ever consider participating in a clinical trial? Although there are many definitions of clinical trials, they are generally considered to be biomedical or health-related research studies in human beings that follow a pre-defined protocol.
People participating in clinical trials have access to experimental medications or devices before they become available to the general public. If you participate, you may receive careful medical attention including examinations and tests at no cost. In some cases, you may be reimbursed for your time and expenses, such as travel.
And some people like the idea that they are contributing to medical science.
To search for clinical trials, go to: http://clinicaltrials.gov
There is a new phase I trial is studying quality of life in younger leukemia and lymphoma survivors.
• To collect preliminary data to determine the extent to which there is impairment in quality of life of young adult survivors of hematologic malignancies.
• To identify the most common areas of concern in these survivors.
• To explore patterns of quality-of-life impairment associated with age, gender, and type of treatment (transplant vs non-transplant) in these survivors.
Patients are assessed in a telephone interview using a brief demographic and clinical data form, then undergo quality-of-life assessment by the Cancer Patient/Cancer Survivor Version questionnaire via telephone.
For more information, go to:
http://localclinicaltrials.com/NCT00956475/Quality-of-Life-in-Younger-Le...

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap